2m 2m 2m 2m 2m 2m 2m
PTC Therapeutics (PTCT)
NASDAQ
$68.01+$0.0010 (+0.001%)
Price as of Aug 03, 2026 5:35 AM EDT- $5.6BMarket Cap
- 30.46%1-Year Change
- BiotechnologyIndustry
PTC Therapeutics (PTCT)
$68.01+$0.0010 (+0.001%)
PTCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $68.01 | ||
Change | -$7.51 (-9.94%) | ||
Open | $70.92 | ||
High | $73.72 | ||
Low | $64.57 | ||
Previous Close | $75.52 | ||
Volume | 4,329,505 | ||
30-Day Average Volume | 1,724,156 | ||
1-Week Change | -11.47% | ||
1-Month Change | -16.62% | ||
1-Year Change | 30.46% | ||
3-Year Change | 68.59% | ||
5-Year Change | 77.43% | ||
Fundamentals | |||
Shares Outstanding | 82.9M | ||
Total Assets | $3.3B | ||
Market Cap | $5.6B | ||
Enterprise Value | $5.2B | ||
Period: QTR TTM FY | |||
Revenue | $238.8M | ||
Net Income | $83.5M | ||
Free Cash Flow | $126.9M | ||
EBIT | $146.0M | ||
EBITDA | $161.9M | ||
Net Working Capital | $1.8B | ||
EPS | $0.92 | ||
Enterprise Value/EBITDA | 32 | ||
Enterprise Value/Revenue | 22 | ||
P/B | -34 | ||
P/E | 74 | ||
PEG | 0 | ||
Price/Free Cash Flow | 44 | ||
Price/Operating Cash Flow | 44 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue